|
CTEPH (n = 135)
|
---|
Age (years)
|
64 (52–70)
|
Male/female, n
|
27/108
|
Body weight (kg)
|
52.9 (48.0–60.4)
|
BMI (kg/m2)
|
21.6 (20.0–23.8)
|
WHO-FC (I: II: III: IV)
|
10:74:50:1
|
Type (occult/recurrent)
|
80/55
|
Hb (g/dL)
|
13.8 (12.6–14.8)
|
BNP (pg/mL)
|
86.3 (29.2–288)
|
CRP (g/dL)
|
0.1 (0.1–0.2)
|
ATIII (%)
|
99 (89.8–109)
|
Systolic blood pressure (mmHg)
|
124 (110–142)
|
Diastolic blood pressure (mmHg)
|
73 (63–82)
|
mPAP (mmHg)
|
43 (35–51)
|
PVR (dyne sec cm−5)
|
689 (482–983)
|
RAP (mmHg)
|
8.0 (6.0–11.5)
|
CO (L/min)
|
3.90 (3.37–4.61)
|
CI (L/min/m2)
|
2.53 (2.18–2.95)
|
PaO2 (mmHg)
|
56 (51.8–65.9)
|
PaCO2 (mmHg)
|
37.7 (34.3–42.7)
|
PvO2 (mmHg)
|
33.8 (31.1–35.9)
|
SvO2 (%)
|
62.7 (58.5–68.5)
|
AaDO2 (mmHg)
|
48.0 (39.9–53.4)
|
6MWD (m)
|
369 (306–424)
|
CTA obstruction score
|
26 (18–34)
|
- Values are expressed as the median with the interquartile range
- BMI, body mass index; WHO-FC, WHO-functional class; Hb, hemoglobin; BNP, brain natriuretic peptide; CRP, C-reactive protein; ATIII, antithrombin III; mPAP, mean pulmonary arterial pressure; PVR, pulmonary vascular resistance; CO, cardiac output; CI, cardiac index; PaO2, partial pressure of arterial oxygen; PaCO2, partial pressure of arterial carbon dioxide; PvO2, mixed venous oxygen pressure; SvO2, mixed venous oxygen saturation; AaDO2, alveolar-arterial oxygen difference; 6MWD, 6-minute walk distance; CTA, CT angiogram